|
TRDA Entrada Therapeutics Inc 1689375 |
| Balance Sheet |
|
Current Assets
|
$232,704,000.00 |
|
Assets
|
$298,877,000.00 |
|
Current Liabilities
|
$21,371,000.00 |
|
Liabilities
|
$65,466,000.00 |
|
Equity
|
$233,411,000.00 |
|
Shares Out
|
38936669.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-74,158,000.00 |
|
Investing Cash Flow
|
$81,936,000.00 |
| Market Analysis |
Market Cap
|
$295,918,684.40 |
|
Price
|
$7.60 |
|
BVPS
|
5.99 |
|
PB
|
1.27 |
|
EPS
|
-1.01 |
|
PS
|
82.38 |
|
FCF
|
$-74,213,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:45 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:36 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
-0.94 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-07 |
-0.95 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-06 |
-1.04 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-1.06 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TRDA documents filed with the SEC.
TRDA Filings
Clear
